| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $1.8M | -42.0% |
| SG&A Expense | $3.7M | -47.2% |
| Operating Income | -$5.8M | +46.7% |
| Pre-tax Income | -$7.0M | +38.9% |
| Net Income | -$7.0M | +38.9% |
| EPS (Basic) | -$8.93 | +84.3% |
| EPS (Diluted) | -$8.93 | +84.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Inventory | $0 | — |
| Current Assets | $968K | -71.8% |
| Total Assets | $3.9M | -13.4% |
| Current Liabilities | $751K | +24.1% |
| Total Liabilities | $1.6M | -15.8% |
| Stockholders' Equity | $2.3M | -11.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$5.2M | +30.0% |
| Capital Expenditures | $17K | +8.0% |
| Investing Cash Flow | -$3.0M | — |
| Financing Cash Flow | $5.7M | -26.6% |
| Free Cash Flow | -$5.2M | +29.9% |